Genius Sports (GENI): Mark Locke filed Amendment No. 4 to Schedule 13G reporting beneficial ownership of 17,070,924 ordinary shares, representing 7.2% of the class. The filing lists sole voting and sole dispositive power over the same 17,070,924 shares and no shared powers.
The percentage is calculated based on 238,718,120 shares outstanding as of September 30, 2025, as referenced from an Exhibit to a Form 6-K. The date of event requiring the filing is September 30, 2025. The reporting person is Mark Locke, Chief Executive Officer of Genius Sports Limited.
Genius Sports (GENI): ownership update. Capital Research Global Investors filed an amended Schedule 13G reporting beneficial ownership of 7,869,105 shares of Genius Sports common stock, equal to 3.3% of the class as of September 30, 2025. The filer has sole voting and sole dispositive power over these shares. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Genius Sports Limited (GENI): Wellington Management Group LLP and affiliates filed a Schedule 13G reporting beneficial ownership of 13,513,537 shares, or 5.63% of GENI common stock, as of 09/30/2025.
The filing lists shared voting power over 9,970,627 shares and shared dispositive power over 13,513,537 shares, with no sole voting or dispositive power. The securities are owned of record by clients of Wellington’s investment adviser subsidiaries.
The certification states the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing also notes no single client is known to have rights over more than five percent of the class.
GENI — Form 144 notice of proposed sale. A holder notified intent to sell 131,608 common shares through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,368,736.36. The approximate sale date is 11/10/2025.
The shares were acquired on 11/07/2025 via restricted stock vesting from the issuer, classified as compensation, in the same amount of 131,608. The table also lists 214,097,454 shares outstanding; this is a baseline figure, not the amount being offered.
Genius Sports (GENI) filed a Form 144 notice for a proposed sale of common stock by an affiliate. The filing lists 400,673 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 11/10/2025 and an aggregate market value of $4,167,039.27.
The shares were acquired via restricted stock vesting on 11/07/2025 from the issuer as compensation. The filing notes 214,097,454 shares outstanding. A Form 144 is a notice of proposed sale under Rule 144 and does not guarantee that the sale will occur.
Genius Sports Limited announced its 2025 Annual General Meeting of Shareholders. The AGM will be held at 2:00 p.m. GMT on December 10, 2025 at Claridge’s, Brook Street, London W1K 4HR, and virtually at https://www.cstproxy.com/geniussports/2025.
The meeting agenda is detailed in the Notice of the 2025 Annual General Meeting (Exhibit 99.1), and a form of proxy to be solicited by the Company is provided as Exhibit 99.2.
Genius Sports Limited furnished a Form 6-K to provide investors with its interim report for the three and nine months ended September 30, 2025 and its third quarter 2025 earnings press release. The interim report is included as Exhibit 99.1 and the earnings press release as Exhibit 99.2. The interim report is also incorporated by reference into several of the company’s existing registration statements on Form F-3 and Form S-8, so those registration statements now include the latest interim financial information.
Genius Sports Limited (GENI) filed a Form 144 reporting a proposed sale of 14,999 common shares with an aggregate market value of $194,462.04. The shares were acquired on 07/19/2025 through restricted stock vesting from the issuer and were paid as compensation. The filing lists Fidelity Brokerage Services LLC as the broker and shows an approximate sale date of 08/25/2025 on the NYSE. The total number of shares outstanding shown is 214,097,454. The filer reports no securities sold in the past three months and affirms no undisclosed material adverse information.
Genius Sports Ltd: This Schedule 13G/A, filed jointly by Caledonia (Private) Investments Pty Limited and Caledonia US, LP, discloses that neither reporting person beneficially owns any ordinary shares of Genius Sports Ltd (CUSIP G3934V109) as of the filing. Both filers report 0 shares and 0.00% ownership, with no sole or shared voting or dispositive power. The filing confirms the parties file as investment advisers (type IA) and includes a joint filing statement; the signatory is Matthew Moses, General Counsel, dated August 14, 2025.
Genius Sports Limited disclosed that NFL Enterprises LLC and affiliated entities beneficially own 19,000,000 ordinary shares, representing 8.2% of the class as of June 30, 2025. Those shares consist of 19,000,000 ordinary shares issuable upon exercise of penny warrants that are exercisable within 60 days, together with the redemption and cancellation of an equal number of B shares. The ownership percentage is calculated using 232,875,872 ordinary shares outstanding as reported in the prospectus supplement dated January 15, 2025. Reporting persons named are NFL Enterprises LLC, NFL Ventures, L.P., and NFL Ventures, Inc., each a U.S. entity, and the filing shows shared voting and shared dispositive power over the 19,000,000 shares.